Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Single-site, Two-way Crossover Phase 1 Study to Assess the Effect of Repeated Doses of Test Propellant (HFA-152a) on Mucociliary Clearance as Compared to Reference Propellant (HFA-134a) in Healthy Male and Female Participants
Conditions
Interventions
HFA-152a
HFA-134a
+1 more
Locations
1
United Kingdom
GSK Investigational Site
Nottingham, United Kingdom
Start Date
July 29, 2024
Primary Completion Date
October 24, 2024
Completion Date
October 24, 2024
Last Updated
April 14, 2026
NCT06979323
NCT06664619
NCT07431021
NCT07383896
NCT06003569
NCT07282886
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions